市場調査レポート
商品コード
1481941

魚類ワクチンの北米市場：地域別分析 - ワクチンタイプ別、用途別、投与経路別、魚種別、予測（～2030年）

North America Fish Vaccines Market Forecast to 2030 - Regional Analysis - by Vaccine Type, Application, Route of Administration, and Species
表紙：魚類ワクチンの北米市場：地域別分析 - ワクチンタイプ別、用途別、投与経路別、魚種別、予測（～2030年）

出版日
ページ情報
英文 79 Pages
納期
即納可能
魚類ワクチンの北米市場：地域別分析 - ワクチンタイプ別、用途別、投与経路別、魚種別、予測（～2030年）
出版日: 2024年02月28日
発行: The Insight Partners
ページ情報: 英文 79 Pages
納期: 即納可能
GIIご利用のメリット

  • 全表示

  • 概要
  • 図表
  • 目次
概要

北米の魚類ワクチンの市場規模は、2022年に1億6,022万米ドルに達し、2022～2030年にかけてCAGR 6.6%で成長し、2030年には2億6,807万米ドルに達すると予測されています。

養殖産業開拓のための政府の取り組みが北米の魚類ワクチン市場を後押し

水産物の需要が高く、天然魚の年間漁獲量が減少しているため、養殖業は急激に成長しています。そのため、政府は水産養殖産業の成長を改善・支援するためのイニシアチブをとっています。以下は最近の取り組みです。

2021年2月、Foundation for Food & Agriculture Research（FFAR）は、ティラピア湖ウイルスやその他の病気の養殖分野での蔓延を食い止めるワクチンのデリバリーシステムを開発するため、79万326米ドルを助成しました。

Sea Grant Marine Aquaculture Grant Program：この全国規模の競合助成プログラムは、正式名称を「全米海洋水産養殖イニシアチブ（NMAI）」といい、米国における持続可能な海洋水産養殖を推進するための調査と実証のイニシアチブを推進しています。

NOAA Small Business Innovation Research (SBIR)：NOAAのSBIRプログラムは、商業化につながる最先端技術や次世代製品・プロセスへの投資に連邦資金を利用する小規模企業を促進するもので、水産養殖の研究開発への投資を支援しています。

その他のプログラムには、NOAA漁業金融プログラム、海洋漁業イニシアチブ（MARFIN）、その他の地域パイロットプロジェクトなどがあります。

2022年、米国農務省食品農業研究所（NIFA）は、世界の農業セクターに数十億米ドルの損害を与えている動物の病気に対する新しい治療法や予防策を調査するため、1,300万米ドル以上の研究投資を発表しました。これには、ナマズの腸性敗血症を安全かつ有用な方法で予防するために使用できる抗菌性飼料添加物を評価するための、ミシシッピ州立大学への62万5,000米ドルの助成金が含まれます。この研究は、養殖生産者の治療法の開発に貢献し、生産効率を向上させる。

このように、養殖産業の開拓を支援する政府のイニシアティブの増加は、魚類ワクチン市場の成長を促進します。

北米の魚類ワクチンの市場概要

北米の魚類ワクチン市場は、米国、カナダ、メキシコに区分されます。この地域の市場成長は、養殖産業の成長と水産動物由来の食品需要の急増によるものです。米国海洋大気庁によると、米国では年間15億米ドルの養殖収入があります。世界銀行によれば、米国の水産養殖製品の生産量は44万8,000トンです。同出典によると、北米では2021年に約560万匹の魚が生産され、そのうち米国では約470万匹が生産されました。このように、米国における養殖生産の増加は、魚類ワクチン市場の成長を促進しています。

北米の魚類ワクチン市場の収益と2030年までの予測（金額）

北米の魚類ワクチン市場セグメンテーション

北米の魚類ワクチン市場は、ワクチンタイプ、用途、投与経路、魚種、国によって区分されます。

ワクチンタイプ別では、北米の魚類ワクチン市場は不活化ワクチン、弱毒生ワクチン、サブユニットワクチン、組み換えベクターワクチン、その他に区分されます。不活化ワクチンセグメントが2022年に最大の市場シェアを占めました。

用途別では、北米の魚類ワクチン市場は細菌感染、ウイルス感染、寄生虫に区分されます。細菌感染セグメントが2022年に最大の市場シェアを占めました。

投与経路に基づき、北米の魚類ワクチン市場は注射ワクチン、浸漬ワクチン、経口ワクチンに区分されます。注射ワクチンセグメントが2022年に最大の市場シェアを占めました。

魚種別では、北米の魚類ワクチン市場はサケ、マス、ティラピア、その他に区分されます。サケセグメントが2022年に最大の市場シェアを占めました。

国別では、北米の魚類ワクチン市場は米国、カナダ、メキシコに区分されます。米国は2022年の北米の魚類ワクチン市場シェアを独占しました。

Elanco Animal Health Inc、Hipra SA、Merck &Co Inc、Phibro Animal Health Corp、Vaxxinova International BV、Zoetis Inc.は、北米の魚類ワクチン市場で事業を展開する大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 北米の魚類ワクチン市場

第3章 調査手法

  • 対象範囲
  • 2次調査
  • 1次調査

第4章 北米の魚類ワクチン市場：主要産業力学

  • 市場促進要因
    • 水産養殖産業発展への政府の取り組み
    • 水産動物由来の食品に対する需要の急増
  • 市場抑制要因
    • ワクチン認可のための厳しい規制
  • 市場機会
    • 新規魚類ワクチンの開発
  • 今後の動向
    • 魚類ワクチンの技術的進歩
  • 影響分析

第5章 魚類ワクチン市場：北米市場分析

  • 魚類ワクチンの市場収益（1,000米ドル）、2022～2030年

第6章 北米の魚類ワクチン市場 - 収益・予測（～2030年）：ワクチンタイプ別

  • 魚類ワクチン市場の収益シェア：ワクチンタイプ別、2022年・2030年
  • 不活化ワクチン
  • 生ワクチン
  • サブユニットワクチン
  • 組み換えベクターワクチン
  • その他

第7章 北米の魚類ワクチン市場 - 収益・予測（～2030年）：用途別

  • 魚類ワクチン市場の収益シェア：用途別、2022年・2030年
  • 細菌感染
  • ウイルス感染
  • 寄生虫感染

第8章 北米の魚類ワクチン市場 - 収益・予測（～2030年）：投与経路別

  • 魚類ワクチン市場の収益シェア：投与経路別、2022年・2030年
  • 注射ワクチン
  • 浸漬ワクチン
  • 経口ワクチン

第9章 北米の魚類ワクチン市場 - 収益・予測（～2030年）：魚種別

  • 魚類ワクチン市場の収益シェア：魚種別、2022年・2030年
  • サーモン
  • マス
  • ティラピア
  • その他

第10章 北米の魚類ワクチン市場：国別分析

  • 米国
  • カナダ
  • メキシコ

第11章 魚類ワクチン市場：産業情勢

  • 魚類ワクチン市場の成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第12章 企業プロファイル

  • Zoetis Inc
  • Merck & Co Inc
  • HIPRA SA
  • Phibro Animal Health Corp
  • Vaxxinova International BV
  • Elanco Animal Health Inc

第13章 付録

図表

List Of Tables

  • Table 1. North America Fish Vaccine Market Segmentation
  • Table 2. Worldwide Fish Production and Consumption in 2022
  • Table 3. Major Bacterial Diseases in Fish
  • Table 4. Major Viral Diseases in Fish
  • Table 5. Major Parasitic Diseases in Fish
  • Table 6. Atlantic Salmon Production 2020
  • Table 7. US Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 8. US Fish Vaccine Market, by Route of Administration- Revenue and Forecast to 2030 (US$ Thousand)
  • Table 9. US Fish Vaccine Market, by Species- Revenue and Forecast to 2030 (US$ Thousand)
  • Table 10. US Fish Vaccine Market, by Application- Revenue and Forecast to 2030 (US$ Thousand)
  • Table 11. Canada Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 12. Canada Fish Vaccine Market, by Route of Administration- Revenue and Forecast to 2030 (US$ Thousand)
  • Table 13. Canada Fish Vaccine Market, by Species- Revenue and Forecast to 2030 (US$ Thousand)
  • Table 14. Canada Fish Vaccine Market, by Application- Revenue and Forecast to 2030 (US$ Thousand)
  • Table 15. Mexico Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 16. Mexico Fish Vaccine Market, by Route of Administration- Revenue and Forecast to 2030 (US$ Thousand)
  • Table 17. Mexico Fish Vaccine Market, by Species- Revenue and Forecast to 2030 (US$ Thousand)
  • Table 18. Mexico Fish Vaccine Market, by Application- Revenue and Forecast to 2030 (US$ Thousand)
  • Table 19. Recent Inorganic Growth Strategies in the Fish Vaccine Market
  • Table 20. Recent Organic Growth Strategies in Fish Vaccine Market
  • Table 21. Glossary of Terms, Fish Vaccine Market

List Of Figures

  • Figure 1. North America Fish Vaccine Market Segmentation, By Country
  • Figure 2. North America Fish Vaccine Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America Fish Vaccine Market Revenue (US$ Th), 2022 - 2030
  • Figure 5. North America Fish Vaccine Market Revenue Share, by Vaccine Type, 2022 & 2030 (%)
  • Figure 6. Inactivated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 7. Live Attenuated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 8. Subunit Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 9. Recombinant Vector Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 10. Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 11. North America Fish Vaccine Market Revenue Share, by Application, 2022 & 2030 (%)
  • Figure 12. Bacterial Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 13. Viral Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 14. Parasitic: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 15. North America Fish Vaccine Market Revenue Share, by Route of Administration, 2022 & 2030 (%)
  • Figure 16. Injected: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 17. Immersion Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 18. Oral Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 19. Fish Vaccine Market Revenue Share, Species, 2022 & 2030 (%)
  • Figure 20. Salmon: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 21. Trout: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 22. Tilapia: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 23. Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 24. North America: Fish Vaccine Market, by Key Country - Revenue (2022) (US$ Thousand)
  • Figure 25. North America Fish Vaccine Market, By Key Countries, 2022 and 2030 (%)
  • Figure 26. US Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
  • Figure 27. Canada Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
  • Figure 28. Mexico Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
  • Figure 29. Growth Strategies in Fish Vaccine Market
目次
Product Code: BMIRE00029702

The North America fish vaccines market was valued at US$ 160.22 million in 2022 and is expected to reach US$ 268.07 million by 2030; it is estimated to grow at a CAGR of 6.6% from 2022 to 2030.

Government Initiatives to Develop Aquaculture Industry Fuel the North America Fish Vaccines Market

Aquaculture grows exponentially due to the high demand for seafood and decreasing annual catch of wild fish. Thus, governments are taking initiatives to improve and support the growth of the aquacultural industry. Following are a few recent initiatives:

In February 2021, the Foundation for Food & Agriculture Research (FFAR) funded US$ 790,326 to create a delivery system for a vaccine that can help stop the tilapia lake virus and other diseases from spreading in the aquaculture sector.

Sea Grant Marine Aquaculture Grant Program: This nationwide competitive grant program, officially known as the "National Marine Aquaculture Initiative (NMAI)," promotes research and demonstration initiatives to advance sustainable marine aquaculture in the US.

NOAA Small Business Innovation Research (SBIR) Program: NOAA's SBIR program, which promotes small firms to use federal funds to invest in cutting-edge technologies and next-generation products and processes that can lead to commercialization, supports investments in aquaculture research and development.

Some other programs include the NOAA Fisheries Finance Program, Marine Fisheries Initiative (MARFIN), and other regional pilot projects.

In 2022, the USDA National Institute of Food and Agriculture (NIFA) announced a research investment of more than US$ 13 million to investigate new treatments and preventative measures for animal illnesses that cost the global agriculture sector billions of dollars. This included a US$ 625,000 grant to Mississippi State University to assess an antibacterial feed additive that can be used to prevent enteric septicemia in catfish in a secure and useful manner. This study will contribute to developing aquaculture producers' treatment alternatives, improving production efficiency.

Thus, an increase in government initiatives to support developments in the aquaculture industry drives the fish vaccine market growth.

North America Fish Vaccines Market Overview

The North America fish vaccines market is segmented into the US, Canada, and Mexico. The market growth in this region is attributed due to the growing aquaculture industry and surging demand for aquatic animal-derived food products. According to the National Oceanic and Atmospheric Administration, aquaculture generate ~US$ 1.5 billion annually in the US. According to the World Bank, the US produced ~448 thousand metric tons aquacultural products. As per the same source, about 5.6 million fish were produced in 2021 in North America, of which ~4.7 million is produced in the US, which is ~83% of the total region fish production. Thus, the increase in aquaculture production in the US is fueling the growth of the fish vaccines market.

North America Fish Vaccines Market Revenue and Forecast to 2030 (US$ Million)

North America Fish Vaccines Market Segmentation

The North America fish vaccines market is segmented based on vaccine type, application, route of administration, species, and country.

Based on vaccine type, the North America fish vaccines market is segmented into inactivated vaccines, live attenuated vaccines, subunit vaccines, recombinant vector vaccine, and others. The inactivated vaccines segment held the largest market share in 2022.

Based on application, the North America fish vaccines market is segmented into bacterial infection, viral infection, and parasitic. The bacterial infection segment held the largest market share in 2022.

Based on route of administration, the North America fish vaccines market is segmented into injection vaccine, immersion vaccine, and oral vaccine. The injection vaccine segment held the largest market share in 2022.

Based on species, the North America fish vaccines market is segmented into salmon, trout, tilapia, and others. The salmon segment held the largest market share in 2022.

Based on country, the North America fish vaccines market is segmented into the US, Canada, and Mexico. The US dominated the North America fish vaccines market share in 2022.

Elanco Animal Health Inc, Hipra SA, Merck & Co Inc., Phibro Animal Health Corp, Vaxxinova International BV, and Zoetis Inc. are some of the leading companies operating in the North America fish vaccines market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 North America Fish Vaccine Market

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Fish Vaccine Market - Key Industry Dynamics

  • 4.1 Market Drivers:
    • 4.1.1 Government Initiatives to Develop Aquaculture Industry
    • 4.1.2 Surging Demand for Aquatic Animal-Derived Food Products
  • 4.2 Market Restraints
    • 4.2.1 Stringent Regulations for Approval of Vaccine
  • 4.3 Market Opportunities
    • 4.3.1 Development of Novel Fish Vaccine
  • 4.4 Future Trends
    • 4.4.1 Technological Advancements in Fish Vaccine
  • 4.5 Impact Analysis:

5. Fish Vaccine Market - North America Market Analysis

  • 5.1 Fish Vaccine Market Revenue (US$ Th), 2022 - 2030

6. North America Fish Vaccine Market - Revenue and Forecast to 2030 - by Vaccine Type

  • 6.1 Overview
  • 6.2 Fish Vaccine Market Revenue Share, by Vaccine Type, 2022 & 2030 (%)
  • 6.3 Inactivated Vaccines
    • 6.3.1 Overview
    • 6.3.2 Inactivated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 6.4 Live Attenuated Vaccines
    • 6.4.1 Overview
    • 6.4.2 Live Attenuated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 6.5 Subunit Vaccines
    • 6.5.1 Overview
    • 6.5.2 Subunit Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 6.6 Recombinant Vector Vaccine
    • 6.6.1 Overview
    • 6.6.2 Recombinant Vector Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 6.7 Others
    • 6.7.1 Overview
    • 6.7.2 Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)

7. North America Fish Vaccine Market - Revenue and Forecast to 2030 - by Application

  • 7.1 Overview
  • 7.2 Fish Vaccine Market Revenue Share, by Application, 2022 & 2030 (%)
  • 7.3 Bacterial Infection
    • 7.3.1 Overview
    • 7.3.2 Bacterial Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 7.4 Viral Infection
    • 7.4.1 Overview
    • 7.4.2 Viral Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 7.5 Parasitic
    • 7.5.1 Overview
    • 7.5.2 Parasitic: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)

8. North America Fish Vaccine Market - Revenue and Forecast to 2030 - by Route of Administration

  • 8.1 Overview
  • 8.2 Fish Vaccine Market Revenue Share, by Route of Administration, 2022 & 2030 (%)
  • 8.3 Injection vaccine
    • 8.3.1 Overview
    • 8.3.2 Injection vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 8.4 Immersion Vaccine
    • 8.4.1 Overview
    • 8.4.2 Immersion Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 8.5 Oral Vaccine
    • 8.5.1 Overview
    • 8.5.2 Oral Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)

9. North America Fish Vaccine Market - Revenue and Forecast to 2030 - by Species

  • 9.1 Overview
  • 9.2 Fish Vaccine Market Revenue Share, by Species, 2022 & 2030 (%)
  • 9.3 Salmon
    • 9.3.1 Overview
    • 9.3.2 Salmon: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 9.4 Trout
    • 9.4.1 Overview
    • 9.4.2 Trout: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 9.5 Tilapia
    • 9.5.1 Overview
    • 9.5.2 Tilapia: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)

10. North America Fish Vaccine Market - Country Analysis

  • 10.1 North America Fish Vaccine Market, Revenue and Forecast To 2030
    • 10.1.1 Overview
    • 10.1.2 North America Fish Vaccine Market, by Country
      • 10.1.2.1 US
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 US Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
        • 10.1.2.1.3 US: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
        • 10.1.2.1.4 US: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
        • 10.1.2.1.5 US: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
        • 10.1.2.1.6 US: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
      • 10.1.2.2 Canada
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Canada Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
        • 10.1.2.2.3 Canada: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
        • 10.1.2.2.4 Canada: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
        • 10.1.2.2.5 Canada: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
        • 10.1.2.2.6 Canada: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
      • 10.1.2.3 Mexico
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 Mexico Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
        • 10.1.2.3.3 Mexico: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
        • 10.1.2.3.4 Mexico: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
        • 10.1.2.3.5 Mexico: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
        • 10.1.2.3.6 Mexico: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)

11. Fish Vaccine Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Fish Vaccine Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Zoetis Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Merck & Co Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 HIPRA SA
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Phibro Animal Health Corp
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Vaxxinova International BV
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Elanco Animal Health Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms